This is the supplier profile page of Wuhan Mixiang Chemistry Co., Ltd, where buyers can explore products, connect directly with the supplier for pricing inquiries.
China
3.3
Room 02, 2nd Floor
Add Favorite
|
Report Supplier
|
This business has not been verified yet.
If you are the business owner, verify now to manage this profile and connect with verified buyers. Verify Now
Business Description
Wuhan Mixiang Chemistry Co., Ltd. is located in Donghu High tech Development Zone, Wuhan City, Hubei Province. It is a high-tech company that specializes in the research and development, pilot testing services, production, and investment of high-end fine chemicals such as pharmaceutical products and chemical intermediates.
Mianxiang Chemical's main business covers
1: New product development and customization: Technology transfer and consulting for high-end fine chemicals such as pharmaceuticals and chemical intermediates, product development, green process improvement and optimization, production process design and control, product customization and sales;
2: Technology transfer and consulting: Formula design and analysis, literature transmission, patent writing, drug application and consistency evaluation;
3: Government university enterprise cooperation: Bridging government university enterprise cooperation.
The R&D team of Wuhan Aminxiang Chemical Co., Ltd. Relies on Professor Wang Kai's team from the School of Health Science and Engineering at Hubei University. The team is mainly composed of doctors, masters, and engineers, and specializes in the research and development of high-end fine chemicals. They have rich experience and expertise in the research and development of pharmaceutical and chemical products and their intermediates, as well as the ability to solve production technology problems.
R&D Team Introduction:
Company founder: pH. D., professor, and doctoral supervisor from Hubei University
· Director of Hubei Functional Chemicals Engineering Technology Research Center
· Hubei Province Academician Expert Selection, Hubei Province's First Batch of Science and Technology Vice Presidents for Small and Medium sized Enterprises, and Ezhou City Science and Technology Commissioner
· Expert in project review and acceptance of Beijing Municipal Government, Zhejiang Province, Jiangxi Province, Hubei Provincial Department of Science and Technology, and Hubei Provincial Department of Economy and Information Technology
· Part time Researcher at Hubei Jiangxia Laboratory
The company has three technical service teams: Process research and development team, product customization and new product research team, and technology transfer and consulting service team, with rich experience and capabilities in pharmaceutical and chemical product research and development.
Team Leader 1: PhD and Associate Professor from Wuhan University, Chutian Student, Visiting Scholar at Rutgers University in the United States, and Vice Dean of Xuandu Industrial Research Institute. Main research direction: Asymmetric hydrogenation reaction synthesis of chiral fragment containing pharmaceutical intermediates.
Team Leader 2: Chutian Student, Associate Professor, PhD from Hong Kong Baptist University, and postdoctoral fellow from Imperial College London, with a main research focus on the design and development of multifunctional new drugs for imaging and therapy.
Team Leader 3: PhD from Central China Normal University and postdoctoral fellow from Peking University. The main research focus is on developing new anti-cancer agents or drugs based on coordination chemistry and analyzing potential mechanisms of action.
Mianxiang Chemical's main business covers
1: New product development and customization: Technology transfer and consulting for high-end fine chemicals such as pharmaceuticals and chemical intermediates, product development, green process improvement and optimization, production process design and control, product customization and sales;
2: Technology transfer and consulting: Formula design and analysis, literature transmission, patent writing, drug application and consistency evaluation;
3: Government university enterprise cooperation: Bridging government university enterprise cooperation.
The R&D team of Wuhan Aminxiang Chemical Co., Ltd. Relies on Professor Wang Kai's team from the School of Health Science and Engineering at Hubei University. The team is mainly composed of doctors, masters, and engineers, and specializes in the research and development of high-end fine chemicals. They have rich experience and expertise in the research and development of pharmaceutical and chemical products and their intermediates, as well as the ability to solve production technology problems.
R&D Team Introduction:
Company founder: pH. D., professor, and doctoral supervisor from Hubei University
· Director of Hubei Functional Chemicals Engineering Technology Research Center
· Hubei Province Academician Expert Selection, Hubei Province's First Batch of Science and Technology Vice Presidents for Small and Medium sized Enterprises, and Ezhou City Science and Technology Commissioner
· Expert in project review and acceptance of Beijing Municipal Government, Zhejiang Province, Jiangxi Province, Hubei Provincial Department of Science and Technology, and Hubei Provincial Department of Economy and Information Technology
· Part time Researcher at Hubei Jiangxia Laboratory
The company has three technical service teams: Process research and development team, product customization and new product research team, and technology transfer and consulting service team, with rich experience and capabilities in pharmaceutical and chemical product research and development.
Team Leader 1: PhD and Associate Professor from Wuhan University, Chutian Student, Visiting Scholar at Rutgers University in the United States, and Vice Dean of Xuandu Industrial Research Institute. Main research direction: Asymmetric hydrogenation reaction synthesis of chiral fragment containing pharmaceutical intermediates.
Team Leader 2: Chutian Student, Associate Professor, PhD from Hong Kong Baptist University, and postdoctoral fellow from Imperial College London, with a main research focus on the design and development of multifunctional new drugs for imaging and therapy.
Team Leader 3: PhD from Central China Normal University and postdoctoral fellow from Peking University. The main research focus is on developing new anti-cancer agents or drugs based on coordination chemistry and analyzing potential mechanisms of action.
Export Capabilities
Declared by supplierWuhan Mixiang Chemistry Co., Ltd has been exporting since 2023. The company ships out of the Port of Wuhan, Shanghai, Ningbo, Qingdao, etc..
Export start year
2023
Logistics and terms accepted
Trade Capabilities
Business Terms
Trade Ability
